REQUEST A DEMO
Total
USD $0.00
Search more companies

Kebopharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KEBOPHARMA Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Kebopharma Bt. is based in Hungary, with the head office in Bekes. It operates in the Pharmacies and Drug Stores industry. It was incorporated on June 11, 1996. 7 (2024) employees currently work for Kebopharma Bt.. From the latest financial highlights, Kebopharma Bt. reported a net sales revenue increase of 12.72% in 2023. During that time, Kebopharma Bt.’s total assets grew by 7.76%. In 2023, Kebopharma Bt.’s net profit margin decreased by 1.69%.

Headquarters
Rakoczi u. 3.
Bekes; Bekes; Postal Code: 5630

Contact Details: Purchase the Kebopharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Kebopharma Bt. report to view the information.
Outstanding Shares:
Purchase the Kebopharma Bt. report to view the information.
Registered Capital:
Purchase the Kebopharma Bt. report to view the information.
Financial Auditors:
Purchase the Kebopharma Bt. report to view the information.
Incorporation Date:
June 11, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Kebopharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.72%
Total operating revenue
11.58%
Operating profit (EBIT)
-31.66%
EBITDA
-15.78%
Net Profit (Loss) for the Period
-31.66%
Total assets
7.76%
Total equity
-7.66%
Operating Profit Margin (ROS)
-1.85%
Net Profit Margin
-1.69%
Return on Equity (ROE)
-7.73%
Quick Ratio
0.04%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?